Figures & data
Table 1 Double-blind, randomized, placebo-controlled studies of LAMA therapy with durations of at least 6 months
Table 2 Lung function in patients receiving LAMA therapy, compared with placebo, in double-blind, randomized, placebo-controlled studies ≥6 months in duration
Table 3 Effect on exacerbations in patients receiving LAMA therapy, compared with placebo, in double-blind, randomized, placebo-controlled studies ≥6 months in duration
Table 4 Dyspnea, health status, and rescue medication use in patients receiving LAMA therapy, compared with placebo, in double-blind, randomized, placebo-controlled studies ≥6 months in duration
Table 5 AEs in patients receiving LAMA therapy, compared with placebo, in double-blind, randomized, placebo-controlled studies ≥6 months in duration
Table 6 Inhalers used with LAMAs for COPD